Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

The proof can be found in this PR.

"the data from its Phase 1 trial of the Company’s anti-psoriasis drug candidate Prurisol™ for the conversion of Prurisol to abacavir indicated “the areas are within passing Bioequivalency limits.” Cellceutix believes it has met the primary endpoints and objectives of the study."

http://cellceutix.com/cellceutix-anti-psoriasis-drug-prurisol-meets-primary-endpoint-of-clinical-trial/#sthash.ccq2wcR3.dpbs

Prurisol 25% Bioavailability

http://cellceutix.com/cellceutix-signs-agreement-for-clinical-trial-in-europe-on-new-psoriasis-drug/#sthash.pmd1P8rH.dpbs

Ziagen 83% Bioavailability

http://www.rxlist.com/ziagen-drug/clinical-pharmacology.htm